The University of Chicago Header Logo

Connection

Larry Goldstein to Cholesterol, HDL

Back to Details
This is a "connection" page, showing publications Larry Goldstein has written about Cholesterol, HDL.
Larry Goldstein
Connection Strength
0.200
Cholesterol, HDL
  1. Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Atherosclerosis. 2009 Jun; 204(2):515-20.
    View in: PubMed
    Score: 0.078
  2. Statins for stroke prevention. Curr Atheroscler Rep. 2007 Oct; 9(4):305-11.
    View in: PubMed
    Score: 0.073
  3. Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients. Stroke. 2014 May; 45(5):1429-36.
    View in: PubMed
    Score: 0.029
  4. Relative and cumulative effects of lipid and blood pressure control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels trial. Stroke. 2009 Jul; 40(7):2486-92.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.